Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

August 25, 2015

Primary Completion Date

February 18, 2019

Study Completion Date

February 18, 2019

Conditions
Specific Developmental Disorders of Scholastic Skills
Interventions
DRUG

Tenoten for children

Tablet for oral use.

DRUG

Placebo

Tablet for oral use.

Trial Locations (10)

117997

"Federal State Budgetary Educational Institution of Higher Education Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation", Moscow

129110

"Moscow Regional Research and Clinical Institute (MONIKI)", Moscow

196191

"St. Petersburg State Budgetary Institution of Health Children's City Polyclinic № 35", Saint Petersburg

197022

Pediatric Research and Clinical Center for Infectious Diseases, Saint Petersburg

344065

"Municipal budgetary health care institution Children's City Polyclinic № 4 of Rostov-on-Don", Rostov-on-Don

350007

"The State Budgetary Healthcare Institution Specialized Clinical Psychiatric Hospital No. 1 of the Krasnodar Region Health Department", Krasnodar

420012

"Federal State Budgetary Educational Institution of Higher Education Kazan Medical University of the Ministry of Healthcare of the Russian Federation", Kazan'

603159

"Limited Liability Company NIZHMEDCLINIKA", Nizhny Novgorod

620149

"State Budgetary Healthcare Institution of Sverdlovsk Region Children's Clinical Hospital of Rehabilitation The Scientific and Practical Center Bonum", Yekaterinburg

630064

"LLC City Neurological Center Sibneyromed", Novosibirsk

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT03159104 - Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children | Biotech Hunter | Biotech Hunter